Srinivas Akkaraju, Director, 10% Owner at Mineralys Therapeutics, Inc. (MLYS), bought 4,519,361 shares at $16.00 ($15.0M) on 2023-02-14, disclosed to the SEC on 2023-02-16.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 3,581,861 | $0 | 0.0% |
| 2 | $16.00 | 937,500 | $15.0M | 100.0% |
| Total | $3.32 avg | 4,519,361 | $15.0M | 100% |
| Filing → |
| KLRS | BUY | 2026-05-22 | $1.2M | — | Filing → |
| ALMS | BUY | 2026-01-13 | $10.0M | — | Filing → |
| SRRK | BUY | 2025-12-16 | $1.9M | — | Filing → |